๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Budesonide CIR capsules once or twice daily in active Crohn's disease. A randomized placebo controlled study in the USA

โœ Scribed by Tremaine, William J.; Hanauer, Stephen B.; Katz, Seymour; Winston, Barry D.; Levine, Jeffrey G.; Persson, Tore; Persson, Anders


Book ID
124138296
Publisher
Elsevier Science
Year
2001
Tongue
English
Weight
174 KB
Volume
120
Category
Article
ISSN
0016-5085

No coin nor oath required. For personal study only.


๐Ÿ“œ SIMILAR VOLUMES


Twice-daily, low-dose pramipexole in ear
โœ Karl Kieburtz; The Parkinson Study Group PramiBID Investigators ๐Ÿ“‚ Article ๐Ÿ“… 2010 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 137 KB ๐Ÿ‘ 1 views

## Abstract To compare the safety and efficacy of low dosages of pramipexole given twice daily (bid) in early Parkinson's disease (PD) with those of a standard 3 times daily (tid) regimen in a randomized, doubleโ€blind, placebo controlled trial involving 311 early PD patients not receiving dopaminer

Ciprofloxacin or metronidazole for the t
โœ Kelvin T. Thia; Uma Mahadevan; Brian G. Feagan; Cindy Wong; Alan Cockeram; Alain ๐Ÿ“‚ Article ๐Ÿ“… 2009 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 99 KB ๐Ÿ‘ 2 views

Background: Although metronidazole and ciprofloxacin are used to treat perianal Crohn's disease (CD), no placebo-controlled trials have been performed. ## Methods: We performed a placebo-controlled pilot trial to evaluate the efficacy and safety of metronidazole and ciprofloxacin in patients with